Tatiana Vidaurre

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

Kenneth R. Hess, K. Anderson, W. Fraser Symmans et al. · Journal of Clinical Oncology · 2006 · 728 citations

Medicine, Oncology, Pharmacology +13

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Adel Tabchy, Vicente Valero, Tatiana Vidaurre et al. · Clinical Cancer Research · 2010 · 212 citations · Full text

Medicine, Oncology, Pharmacology +15

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Libero Santarpia, Yuan Qi, Katherine Stemke‐Hale et al. · Breast Cancer Research and Treatment · 2012 · 110 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

Carlos A. Castañeda, Elizabeth A. Mittendorf, Sandro Casavilca‐Zambrano et al. · World Journal of Clinical Oncology · 2016 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +12

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women

Katie M. Marker, Valentina A. Zavala, Tatiana Vidaurre et al. · Cancer Research · 2020 · 56 citations · Full text

Medicine, Genetics, Oncology +16